Discover 1,609 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,609
Active & Responsive
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
for
Non-small Cell Lung Cancer
Location: Raleigh NC, Albany NY, Lincoln NE
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07554339
Phase3, Recruiting
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: Raleigh NC, Fredericksburg VA, Asheville NC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase3, Recruiting
Active & Responsive
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: Raleigh NC, Wilmington NC, Morehead City NC,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Raleigh NC, Cary NC, Durham NC, Petersburg VA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase3, Recruiting
Active & Responsive
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
for
Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU)
Location: Raleigh NC, Cary NC, Salem VA, Blue Ash OH, Boardman OH,
Sponsor: HealthTech Wound Care
Sex: All
Age: 18 - 70+
Code: NCT07172893
Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Raleigh NC, Winston-Salem NC, Morehead City NC,
Location: Raleigh NC, Charleston SC, Philadelphia PA,
Sponsor: Cerus Endovascular, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06693011
Recruiting
Active & Responsive
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: Raleigh NC, Chapel Hill NC, Concord NC,
Sponsor: Penumbra Inc.
Sex: All
Age: 18+
Code: NCT06747117
Recruiting
Active & Responsive
Fertilo In Vitro Research Study and Trial
for
In Vitro Maturation of Oocytes
Location: Raleigh NC, Charlotte NC, Rockville MD, New York NY,
Sponsor: Gameto, Inc.
Sex: Female
Age: 18 - 35
Code: NCT06858111
Phase3, Recruiting
Active & Responsive
VTP-1000 in Adults With Celiac Disease
for
Celiac Disease
Location: Raleigh NC, Richmond VA, Baltimore MD, Columbus OH,
Sponsor: Barinthus Biotherapeutics
Sex: All
Age: 18 - 70
Code: NCT06310291
Early_phase1, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Raleigh NC, Durham NC, Chapel Hill NC, Goldsboro NC,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Raleigh NC, Durham NC, Chapel Hill NC, Fayetteville NC,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Raleigh NC, Durham NC, Chapel Hill NC, Fayetteville NC,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)